CEVOSTAMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 16:19:49 GMT 2023` Edited by `admin` on `Sat Dec 16 16:19:49 GMT 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	P86BHN01VE
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CEVOSTAMAB

Official Name

English

ANTI-FCRH5/CD3 BITE ANTIBODY BFCR4350A

Common Name

English

BFCR-4350A

Code

English

FCRH5/CD3 T CELL DEPENDENT BISPECIFIC ANTIBODY BFCR4350A

Common Name

English

RO7187797

Code

English

BFCR4350A

Code

English

Cevostamab [WHO-DD]

Common Name

English

RECOMBINANT ANTI-FCRH5 X ANTI-CD3 BI-SPECIFIC T-CELL ENGAGER BFCR4350A

Common Name

English

RO-7187797

Code

English

BFCR4350A (ANTI-FCRH5/CD3 T-CELL DEPENDENT BISPECIFIC ANTIBODY)

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FC RECEPTOR-LIKE PROTEIN 5, FCRL5 (BXMAS1, FC RECEPTOR HOMOLOG 5, IMMUNE RECEPTOR TRANSLOCATION-ASSOCIATED PROTEIN 2, CD307E-ANTIGEN)) AND ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN, CD3E

Common Name

English

CEVOSTAMAB [USAN]

Common Name

English

cevostamab [INN]

Common Name

English

IMMUNOGLOBULIN G1 (300-GLYCINE,369-TRYPTOPHAN), ANTI-(HUMAN FC RECEPTOR-LIKE PROTEIN FCRL5) (HUMAN-MUS MUSCULUS MONOCLONAL KFCR8534A .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL KFCR8534A .KAPPA.-CHAIN, DIMER WITH IMMUNOGLOBULIN G1 (299-

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

799220